At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Daytrana +3 moredrug
Likely dose
Daytrana 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open Label Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
In Brief
A clinical study evaluating Daytrana for Attention Deficit Hyperactivity Disorder and INSOMNIA. Completed, enrolled 26 participants across 1 site.
Detailed Summary
Methylphenidate may improve sleep in children with ADHD. By leaving Daytrana (methylphenidate) patch for a longer time then 9 hours, many children report short sleep latencies and better quality of sleep.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Hyperactivity Disorder, INSOMNIA
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2009
Enrollment StartDec 2009
Primary CompletionFeb 2011
TodayJul 2026
First PostedOct 6, 2009
Enrollment StartDec 1, 2009
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.7 years ago
Interventions
Daytranadrug
Daytrana patch 10-30 mg administered once daily for 9hr
Daytranadrug
Daytrana 10-30 mg worn once daily for 10 hr wear
Daytranadrug
Daytrana 10-30 mg worn once daily for 11 hr
Daytranadrug
Daytrana 10-30 mg worn once daily for 12 hrs